Skip to main content

Table 3 Characteristics of psychotropic drugs at the start of the study

From: Psychotropic drug use among people with dementia – a six-month follow-up study

Drug n (%) Dose, mean (mg) ± SD Range (mg) Dose, median (mg)
Antidepressants (N06A)     
Citalopram 84 (52.5) 19.6 ± 6.1 10-40 20.0
Clomipramine 1 (0.6) 175.0   175.0
Escitalopram 1 (0.6) 10.0   10.0
Sertraline 32 (20.0) 68.0 ± 31.3 25-150 50.0
Mianserine 8 (5.0) 27.5 ± 10.3 10-40 30.0
Mirtazapine 26 (16.3) 30.6 ± 7.9 15-60 30.0
Venlafaxine 8 (5.0) 112.5 ± 56.7 75-225 75.0
Anxiolytics (N05B)     
Hydroxyzine 7 (15.9) 32.9 ± 22.1 10-75 25.0
Diazepam 1 (2.3) 3.3   3.3
Oxazepam 31 (70.5) 24.0 ± 26.8 5-135 15.0
Alprazolam 4 (9.0) 2.6 ± 2.5 0.5-6 2.0
Buspirone 1 (2.3) 15.0   15.0
Hypnotics and sedatives (N05C)     
Clometiazol 35 (26.3) 651.4 ± 273.7 300-1500 600.0
Flunitrazepam 15 (11.3) 0.7 ± 0.3 0.5-1 0.5
Propiomazine 37 (27.8) 33.4 ± 12.5 12-50 25.0
Zolpidem 19 (14.3) 6.4 ± 2.5 2.5-10 5.0
Zopiclone 27 (20.3) 6.9 ± 2.2 5-15 7.5
  1. n = number of prescriptions, percent is calculated within each drug group.